小肠腺癌发病机制和诊治的研究进展  

Research progress in pathogenesis,diagnosis and treatment of small bowel adenocarcinoma

作　　者：王士宁(综述) 李明[1] 谭诗云(审校)[1] Wang Shining;Li Ming;Tan Shiyun(Department of Gastroenterology,Renmin Hospital of Wuhan University,Hubei Provicne,Wuhan 430060,China)

机构地区：[1]武汉大学人民医院消化内科/消化系统疾病湖北省重点实验室,430060

出　　处：《疑难病杂志》2022年第8期881-884,共4页Chinese Journal of Difficult and Complicated Cases

基　　金：国家自然科学基金资助项目(82004114)。

摘　　要：小肠腺癌(SBA)是罕见的消化系统肿瘤,近年来发病率不断上升,约占小肠肿瘤的40%,其最佳管理缺乏前瞻性的数据支持。近年来,国内外对有关SBA的致病因素、遗传学及分子机制、临床分期、临床特征、诊断及治疗进行了相关研究,文章对其研究进展进行综述。Small bowel adenocarcinoma(SBA)is a rare digestive system tumor with an increasing incidence in recent years,accounting for about 40%of small bowel tumors,and its optimal management lacks prospective data support.In recent years,relevant researches on the pathogenic factors,genetics and molecular mechanisms,clinical staging,clinical features,diagnosis and treatment of SBA have been carried out at home and abroad.This article reviews the research progress.

关 键 词：小肠腺癌 致病因素 遗传学及分子机制 临床特征 诊断 治疗 

分 类 号：R735.32[医药卫生—肿瘤]